Ahmad Abdallah Obeidat

Dr. Ahmad Abdallah Obeidat

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AOAhmad Abdallah Obeidat
Ahmad Abdallah Obeidat
Mousa Numan AhmadMousa Numan Ahmad
Mousa Numan Ahmad
MGMai Adil Ghabashi
Mai Adil Ghabashi
AAAwfa Yosef Alazzeh
Awfa Yosef Alazzeh
SHSalam Habib
Salam Habib
FAFiras Azzeh
Firas Azzeh
Background/Objectives: Metabolic syndrome (MetS) is a complex disorder characterized by insulin resistance (IR), central obesity, atherogenic dyslipidemia, and higher glucose levels. It increases the risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM), imposing an economic burden on the healthcare system. However, the historical origins of MetS as well as the development and evolution of its definitions have not been conclusively documented in the literature. This study seeks to enhance the understanding of the developmental trends of MetS during the preceding two decades, placing particular emphasis on the definition, diagnosis and prevalence. Methods: An extensive search was performed from 1920 to 2023 across prominent scientific research engines, including Scopus, PubMed, MDPI, and others. Results: Despite advancements, many aspects of MetS remain inadequately understood. As the understanding of the nature and pathophysiology of MetS progresses, the development and refinement of its diagnostic criteria, and assessment and treatment guidelines will continue. Additionally, there exists significant variation in the global prevalence of metabolic syndrome, ranging from 14 to 39%. This prevalence is projected to increase due to the adoption of less healthy dietary patterns and sedentary lifestyles. The observed disparities in metabolic syndrome prevalence can be attributed to multiple factors, including demographic characteristics. Furthermore, the lack of a standardized definition across studies also contributes to the variation in reported prevalence rates. Conclusions: Further studies focusing on the standardization of the MetS definition across different research are crucial. The establishment of consistent criteria would enhance the reliability and validity of research findings, enabling more meaningful comparisons and interpretations.

18 January 2024 in Cancers
Verified
Journal Article
Open access
PDF file
ARAlaa S. Redwan
Alaa S. Redwan
FKFayrooz A. Kattan
Fayrooz A. Kattan
MAMaha A. Alidrisi
Maha A. Alidrisi
GAGayur A. Ali
Gayur A. Ali
MGMAZEN GHAITH
MAZEN GHAITH
FAFiras Azzeh
Firas Azzeh
Weight loss is a significant health problem among patients with head and neck cancer (HNC) that is attributable primarily to the tumor or tumor therapy. Critical weight loss (CWL) is defined as the unintentional loss of ≥5% of weight. Therefore, this study’s goal was to investigate and determine the possible factors influencing CWL among patients with HNC who have received radiotherapy or concurrent chemoradiotherapy (CCRT). We conducted a retrospective analysis of 175 patients who received radiotherapy or CCRT as either their primary, adjuvant, or combined treatment at the Oncology Center in King Abdullah Medical City. All patients were ≥18 years of age and diagnosed with HNC with no metastasis. The study results showed that 107 patients (61%) had CWL, while 68 (39%) did not. The following factors were significantly predictive of CWL with a multivariate regression analysis: pretreatment BMI (AOR = 1.1, 95% CI = 1.02–1.17), oral cavity cancer (AOR = 10.36, 95% CI = 1.13–94.55), and male sex (AOR = 3.15, 95% CI = 1.39–7.11). In conclusion, weight loss is highly prevalent among HNC patients during treatment. Accordingly, pretreatment BMI, cancer in the oral cavity, and being male can be considered predictive factors for CWL.

23 January 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
AOAhmad Abdallah Obeidat
Ahmad Abdallah Obeidat
MGMai Adil Ghabashi
Mai Adil Ghabashi
AAAwfa Yosef Alazzeh
Awfa Yosef Alazzeh
FAFiras S Azzeh
Firas S Azzeh
Background: Metabolic syndrome (MetS) is a complex disorder characterized by insulin resistance (IR), central obesity, atherogenic dyslipidemia and higher glucose levels. It increases the risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM), imposing an economic burden on the healthcare system. However, the historical origins of MetS as well as the development and evolution of its definitions have not been conclusively documented in the literature. Aim: This study seeks to enhance the understanding of the developmental trends of MetS during the preceding two decades, placing particular emphasis on the definition, diagnosis and prevalence. Methods: An extensive search was performed from 1920 to 2023 across prominent scientific research engines, including Scopus, PubMed, MDPI, and others. Results: Despite advancements, many aspects of MetS remain inadequately understood. As the understanding of the nature and pathophysiology of MetS progresses, the development and refinement of its diagnostic criteria, and assessment and treatment guidelines will continue. Additionally, there exists significant variation in the global prevalence of metabolic syndrome, ranging from 14 to 39%. This prevalence is projected to increase due to the adoption of less healthy dietary patterns and sedentary lifestyles. The observed disparities in metabolic syndrome prevalence can be attributed to multiple factors, including demographic characteristics. Furthermore, the lack of a standardized definition across studies also contributes to the variation in reported prevalence rates. Conclusion: Further studies focusing on the standardization of the MetS definition across different research are crucial. The establishment of consistent criteria would enhance the reliability and validity of research findings, enabling more meaningful comparisons and interpretations.

20 October 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
AOAhmad Abdallah Obeidat
Ahmad Abdallah Obeidat
DADalia M. Abu Al-Haijaa
Dalia M. Abu Al-Haijaa
RRRazan J. Rahahleh
Razan J. Rahahleh
MAMousa N. Ahmad
Mousa N. Ahmad
SJSarah Jaradat
Sarah Jaradat
FAFiras S. Azzeh
Firas S. Azzeh
Introduction: The prevalence of metabolic syndrome (MetS) is difficult to define because there is no universal consensus on the definition of MetS and similarities and differences in definitions of the components and the architecture of the definitions can significantly affect the prevalence and individual classification. The aim of this systematic review was to assess the impact of alternative definitions of MetS on prevalence, diagnostic agreement, reclassification, metabolic components and ethnicity-specific classification. Methods: A systematic review was carried out following the PRISMA 2020 guidelines. Studies met inclusion criteria if they included a comparison of 2 or more MetS diagnostic definitions in the same adult population. Information was gathered about study characteristics, diagnostic frameworks, thresholds for the components of MetS, prevalence of MetS, agreement between the two diagnostic methods, reclassification, and regional or ethnic specific criteria. A descriptive synthesis of finding was completed because of the significant degree of population and diagnostic heterogeneity. Results: Nine studies were included in the evidence synthesis. The prevalence of MetS was highly heterogeneous when the same population was assessed using different diagnostic criteria. The prevalence rates in Finnish adults ranged from 17.7% (WHO criteria) to 43.0% (JIS criteria), and the prevalence rates in the nationwide Iranian study ranged from 32.0% (IDF criteria) to 47.6% (JIS criteria). There was high diagnostic concordance between structurally similar definitions such as between IDF versus JIS in Finland (κ = 0.97) while lower levels of concordance were found between comparisons using WHO criteria. The most frequently reported factors associated with diagnostic discordance were central obesity and waist circumference. In addition, there were significant variations in prevalence of MetS depending on the region-specific adjustment of waist-circumference thresholds. Furthermore, the prevalence of MetS varied significantly by region-specific adjustment of waist circumference thresholds. Discussion: The prevalence of MetS from one diagnostic framework to another may not be directly comparable since it is highly definition-dependent. Waist thresholds may vary by ethnicity and this can be a significant factor in classification. Further research should include precise diagnostic criteria and thresholds, cross-classification data and validation of alternative definitions with clinically relevant outcomes.

30 July 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
AOAhmad Abdallah Obeidat
Ahmad Abdallah Obeidat
MAMousa N. Ahmad
Mousa N. Ahmad
SHSalam M. Habib
Salam M. Habib
DADalia Abu Al-Haijaa
Dalia Abu Al-Haijaa
OAOhaad F. Awlya
Ohaad F. Awlya
FAFiras S. Azzeh
Firas S. Azzeh
Background: The most common traditional anthropometric indices used for metabolic syndrome (MetS) screening may not capture the metabolic risks associated with central adiposity, lipid dysregulation, and sex-specific metabolic risk. The purpose of this study was to compare traditional and derived anthropometric and biochemical parameters in the diagnosis of MetS among Jordanian adults. Methods: In this cross-sectional study, 930 adults (458 men and 472 women), aged 20–70 years, were assessed using harmonized IDF and AHA/NHLBI criteria. Among the traditional anthropometric indices, body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR), and waist-to-hip ratio (WHR) were included. Several derived indices were computed: lipid accumulation product (LAP), visceral adiposity index (VAI), body roundness index (BRI), abdominal volume index (AVI), atherogenic index of plasma (AIP), cardiac risk index (CRI), and related lipid ratios. The diagnostic accuracy was verified using receiver operating characteristic (ROC) curve analysis, sensitivity, specificity, and the Youden index in sex-stratified analyses. Results: Among traditional indices, the results for WC and WHtR were good. The derived indices LAP and VAI were most accurate in both sexes, while the lipid ratios alone failed to provide good discrimination. BRI and AVI also showed good performance in derived anthropometric indices. Significant sex-specific differences were found in index distributions, optimal cutoff values, and their associations with MetS components. Conclusion: Derived lipid-adiposity indices are more discriminatory towards MetS than traditional single anthropometric indices, especially LAP and VAI. WC and WHtR are still good first-line screening tools while biochemical measurements may be used in the stratification of risk with LAP and VAI. The results of this study suggest the need for a multi-dimensional, sex-specific approach to screening for metabolic syndrome. The proposed cut-off values are based on a Jordanian population. Still, the approach of combining anthropometric, biochemical, and imaging-based surrogate markers for metabolic assessment may be transferable to other populations after external validation.